Article
Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience.
Technology in cancer research & treatment - 1 Jan 2000
Jin Gu, Wang Chunyang, Jia Dongdong, Qian Wenkang, Yin Chunming, Wang Danhua, Yang Quanyu, Li Tao, Zheng Aiwen
Abstract excerpt
Background: Next generation sequencing (NGS) has systematically investigated the genomic landscape of soft tissue sarcoma (STS) in Western patients, but few reports have described the utility of NGS in identifying pathogenic and targetable mutations in Asian patients. Methods: We review our single center experience of identifying the genomic profile and feasible genetic mutations in 65 Chinese patients with STS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.